ArticleBMC geriatrics2026
Development and validation of a risk prediction model for oral frailty among Chinese older adults with type 2 diabetes mellitus.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Risk prediction models for oral frailty in older adults: a scoping review.Frontiers in medicine · 2026Pooled it
- Diagnostic Prediction Models for Oral Frailty in Older Adults: A Systematic Review and Critical Appraisal.Patient preference and adherence · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveTo investigate the prevalence and associated factors of oral frailty in older adults with type 2 diabetes, establish a nomogram prediction model, develop an assessment tool for early screening and prevention of oral frailty in this population, and provide scientific basis for the formulation of personalized oral health management strategies.
methodsA convenience sampling method was used to select 533 older adults with type 2 diabetes mellitus who visited two tertiary-level general hospitals in Sichuan Province and one tertiary-level general hospital in Hebei Province from April 2024 to June 2025 as the study subjects. They were randomly divided into a training set and a validation set in a 7:3 ratio. A risk prediction model was constructed through analysis, and a nomogram was drawn. The Hosmer-Lemeshow (H-L) test and receiver operating characteristic (ROC) curve were used to evaluate the model’s goodness of fit and predictive performance, respectively. The constructed model was validated through 1,000 bootstrap sampling iterations to assess its predictive efficacy.
resultsA total of 533 older adults with type 2 diabetes were included in the final analysis. Among them, 246 patients (46.15%) exhibited symptoms of oral frailty. Multivariate logistic regression analysis revealed that age, type of chronic disease, duration of diabetes, HbA1c level, periodontitis, number of natural teeth, difficulty chewing hard foods, and swallowing disorders were associated with the risk of oral frailty in older adults with type 2 diabetes (all P < 0.05); The area under the ROC curve (AUC) of the predictive model was 0.847( 95%CI: 0.808–0.886), a sensitivity of 72.3%, a specificity of 83.5%, and a maximum Youden index of 0.558. Internal validation showed that the area under the ROC curve for the validation set was 0.831(95%CI:0.768–0.894), with a sensitivity of 82.2% and specificity of 72.4%. The Hosmer-Leme-show test yielded χ² = 13.548, P = 0.094 (both > 0.05). The calibration curve showed good agreement between the nomogram model and actual observed values. The ROC and DCA decision curves indicated that the nomogram model has good predictive performance and clinical utility.
conclusionsThe nomogram model developed in this study provides convenience for clinical assessment of the risk of oral frailty in older adults with type 2 diabetes, and helps doctors identify high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.